Activins and the Liver

[1]  W. Berger,et al.  Deregulation of the activin/follistatin system in hepatocarcinogenesis. , 2006, Journal of hepatology.

[2]  Sabine Werner,et al.  Roles of activin in tissue repair, fibrosis, and inflammatory disease. , 2006, Cytokine & growth factor reviews.

[3]  Y. Hasegawa,et al.  Analysis of the function of activin betaC subunit using recombinant protein. , 2006, The Journal of reproduction and development.

[4]  K. Mutoh,et al.  Impaired growth of pancreatic exocrine cells in transgenic mice expressing human activin betaE subunit. , 2006, Biochemical and biophysical research communications.

[5]  C. Robinson,et al.  Structural basis for the inhibition of activin signalling by follistatin , 2006, The EMBO journal.

[6]  D. Endo,et al.  Activin or follistatin: which is more beneficial to support liver regeneration after massive hepatectomy? , 2006, Endocrine journal.

[7]  Y. Takikawa,et al.  Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure , 2006, Journal of gastroenterology and hepatology.

[8]  D. Phillips,et al.  Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[9]  T. Jardetzky,et al.  Structural Basis for a Functional Antagonist in the Transforming Growth Factor β Superfamily* , 2005, Journal of Biological Chemistry.

[10]  A. Mukherjee,et al.  Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3. , 2005, Endocrinology.

[11]  C. Donaldson,et al.  An Activin-A/C Chimera Exhibits Activin and Myostatin Antagonistic Properties* , 2005, Journal of Biological Chemistry.

[12]  H. Kuwano,et al.  Adenovirus-mediated overexpression of the activin betaC subunit accelerates liver regeneration in partially hepatectomized rats. , 2005, Journal of hepatology.

[13]  N. Seidah,et al.  Evidence for proprotein convertase activity in the endoplasmic reticulum/early Golgi , 2005, FEBS letters.

[14]  J. Scheerlinck,et al.  Activin A: from sometime reproductive factor to genuine cytokine. , 2005, Veterinary immunology and immunopathology.

[15]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[16]  M. Hearn,et al.  A molecular recognition paradigm: promiscuity associated with the ligand–receptor interactions of the activin members of the TGF‐β superfamily , 2005, Journal of molecular recognition : JMR.

[17]  David Salomon,et al.  Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis , 2005, Oncogene.

[18]  S. Kloeker,et al.  TGF-β inhibitors for the treatment of cancer , 2005 .

[19]  K. Tsuchida,et al.  Activin and activin receptor expression changes in liver regeneration in rat. , 2005, The Journal of surgical research.

[20]  S. Tashiro,et al.  Effect of follistatin on rat liver regeneration and tumor growth after portal occlusion. , 2005, Hepato-gastroenterology.

[21]  S. Gautam,et al.  Inactivation of TGF-β signaling in hepatocytes results in an increased proliferative response after partial hepatectomy , 2005, Oncogene.

[22]  H. Kuwano,et al.  Comparison of the Function of the βC and βE Subunits of Activin in AML12 Hepatocytes , 2005 .

[23]  G. Risbridger,et al.  βA- and βC-activin, follistatin, activin receptor mRNA and βC-activin peptide expression during rat liver regeneration , 2005 .

[24]  Zhonghui Liu,et al.  Effects of activin A on the activities of the mouse peritoneal macrophages. , 2005, Cellular & molecular immunology.

[25]  L. Ruddock,et al.  The human protein disulphide isomerase family: substrate interactions and functional properties , 2005, EMBO reports.

[26]  D. Rifkin,et al.  Latent TGF-β binding proteins , 2005 .

[27]  H. V. Melchner,et al.  TGF-β activation by traction? , 2004 .

[28]  C. Schmidt‐Weber,et al.  Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. , 2004, Current opinion in immunology.

[29]  Jonathan M. Yingling,et al.  Development of TGF-β signalling inhibitors for cancer therapy , 2004, Nature Reviews Drug Discovery.

[30]  Jonas Larsson,et al.  Intact signaling by transforming growth factor β is not required for termination of liver regeneration in mice , 2004, Hepatology.

[31]  Herbert Y. Lin,et al.  Differential actions of follistatin and follistatin-like 3 , 2004, Molecular and Cellular Endocrinology.

[32]  D. Phillips,et al.  Activin A and follistatin in systemic inflammation , 2004, Molecular and Cellular Endocrinology.

[33]  P. Williams,et al.  Activin redux: specification of mesodermal pattern in Xenopus by graded concentrations of endogenous activin B , 2004, Development.

[34]  T. Waldman,et al.  Interaction of the BMPR-IA tumor suppressor with a developmentally relevant splicing factor. , 2004, Biochemical and biophysical research communications.

[35]  R. Taub.  Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.

[36]  S. Choe,et al.  A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors. , 2004, Molecular cell.

[37]  H. Kuwano,et al.  Assessment of the function of the betaC-subunit of activin in cultured hepatocytes. , 2004, American journal of physiology. Endocrinology and metabolism.

[38]  M. O’Bryan,et al.  Cell-specific expression of βC-activin in the rat reproductive tract, adrenal and liver , 2004, Molecular and Cellular Endocrinology.

[39]  M. Mareel,et al.  Melanoma cells secrete follistatin, an antagonist of activin-mediated growth inhibition , 2004, Oncogene.

[40]  C. Donaldson,et al.  An Activin Mutant with Disrupted ALK4 Binding Blocks Signaling via Type II Receptors* , 2004, Journal of Biological Chemistry.

[41]  K. Jones,et al.  Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe. , 2004, The Journal of endocrinology.

[42]  B. Wiedenmann,et al.  Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells. , 2004, Gastroenterology.

[43]  H. Kuwano,et al.  The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells. , 2004, Endocrinology.

[44]  K. Patel,et al.  Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. , 2004, Developmental biology.

[45]  D. Phillips,et al.  Effect of heparin administration to sheep on the release profiles of circulating activin A and follistatin. , 2004, The Journal of endocrinology.

[46]  P. Galle,et al.  Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells , 2004, Oncogene.

[47]  A. Ludlow,et al.  Latent TGF‐β1 activation by platelets , 2004 .

[48]  D. Endo,et al.  Activin A augments vascular endothelial growth factor activity in promoting branching tubulogenesis in hepatic sinusoidal endothelial cells. , 2004, Journal of hepatology.

[49]  R. Sandler,et al.  Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. , 2004, Gastroenterology.

[50]  A. Roberts,et al.  SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. , 2004, Molecular pharmacology.

[51]  C. Kemp,et al.  Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. , 2004, Reproduction.

[52]  H. Keutmann,et al.  The role of follistatin domains in follistatin biological action. , 2004, Molecular endocrinology.

[53]  I. Sargent,et al.  Endothelial cells and peripheral blood mononuclear cells are a potential source of extraplacental activin a in preeclampsia. , 2003, The Journal of clinical endocrinology and metabolism.

[54]  M. Matzuk,et al.  Activins are critical modulators of growth and survival. , 2003, Molecular endocrinology.

[55]  I. Verma,et al.  Adenovirus‐mediated overexpression of follistatin enlarges intact liver of adult rats , 2003, Hepatology.

[56]  R. Schulte‐Hermann,et al.  Expression of activins C and E induces apoptosis in human and rat hepatoma cells. , 2003, Carcinogenesis.

[57]  J. F. Schmitt,et al.  Activin betaC-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate. , 2003, Endocrinology.

[58]  Mohammad Zafari,et al.  Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. , 2003, The Journal of clinical investigation.

[59]  W. Bursch,et al.  Induction of apoptosis in mouse liver adenoma and carcinoma in vivo by transforming growth factor-β1 , 2003, Journal of Cancer Research and Clinical Oncology.

[60]  K. Herkner,et al.  Overexpression of Activin βC or Activin βE in the Mouse Liver Inhibits Regenerative Deoxyribonucleic Acid Synthesis of Hepatic Cells , 2003 .

[61]  A. Rademaker,et al.  Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer. , 2003, Cancer research.

[62]  A. Schneyer,et al.  Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). , 2003, Endocrinology.

[63]  W. Vale,et al.  Cripto forms a complex with activin and type II activin receptors and can block activin signaling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[64]  T. Jardetzky,et al.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF‐β ligand:receptor interactions , 2003, The EMBO journal.

[65]  C. Redman,et al.  Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the placental tissue of patients with pre-eclampsia. , 2003, Molecular human reproduction.

[66]  Mark Cranfield,et al.  Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis , 2003, Molecular and Cellular Endocrinology.

[67]  B. Vogelstein,et al.  Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. , 2003, Cancer research.

[68]  R. Hughes,et al.  Activin A and follistatin in acute liver failure , 2003, European journal of gastroenterology & hepatology.

[69]  C. Donaldson,et al.  Residues in the C-terminal region of activin A determine specificity for follistatin and type II receptor binding. , 2003, The Journal of endocrinology.

[70]  M. Matzuk,et al.  Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily , 2002 .

[71]  R. Schulte‐Hermann,et al.  Response of isolated hepatocytes from carcinogen sensitive (C3H) and insensitive (C57BL) mice to signals inducing replication or apoptosis , 2002, Archives of Toxicology.

[72]  R. Schulte‐Hermann,et al.  Follistatin overexpression in rodent liver tumors: A possible mechanism to overcome activin growth control , 2002, Molecular carcinogenesis.

[73]  K. Tsuchida,et al.  cDNA cloning and expression of human activin βE subunit , 2002, Molecular and Cellular Endocrinology.

[74]  T. Fujita,et al.  Involvement of Smad proteins in TGF-beta and activin A-induced apoptosis and growth inhibition of liver cells. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

[75]  A. Reith,et al.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. , 2002, Molecular pharmacology.

[76]  R. Schulte‐Hermann,et al.  Expression and dimerization of the rat activin subunits betaC and betaE: evidence for the ormation of novel activin dimers. , 2002, Journal of molecular endocrinology.

[77]  T. Hayakawa,et al.  Effect of activins AB and B on DNA synthesis stimulated by epidermal growth factor in primary cultured rat hepatocytes. , 2002, Biological & pharmaceutical bulletin.

[78]  R. Schulte‐Hermann,et al.  Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. , 2002, Journal of cell science.

[79]  D. Salomon,et al.  Cripto: A tumor growth factor and more , 2002, Journal of cellular physiology.

[80]  M. Yuen,et al.  Transforming Growth Factor-Beta 1, Activin and Follistatin in Patients with Hepatocellular Carcinoma and Patients with Alcoholic Cirrhosis , 2002, Scandinavian journal of gastroenterology.

[81]  P. Heinrich,et al.  Cytokines in liver injury and repair , 2002 .

[82]  G. Risbridger,et al.  Activins and inhibins in endocrine and other tumors. , 2001, Endocrine reviews.

[83]  M. Mori,et al.  Transforming growth factor β and activin tonically inhibit DNA synthesis in the rat liver , 2001 .

[84]  D. Roulot,et al.  Transforming growth factor β and the liver , 2001 .

[85]  G. Risbridger,et al.  Activins as regulators of branching morphogenesis. , 2001, Developmental biology.

[86]  J. Kleeff,et al.  Overexpression of activin A in stage IV colorectal cancer , 2001, Gut.

[87]  A. Schneyer,et al.  Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. , 2001, Endocrinology.

[88]  H. Keutmann,et al.  Follistatin-related protein (FSRP): a new member of the follistatin gene family , 2001, Molecular and Cellular Endocrinology.

[89]  M. Hedger,et al.  Evidence for activin A and follistatin involvement in the systemic inflammatory response , 2001, Molecular and Cellular Endocrinology.

[90]  C. Heldin,et al.  Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation. , 2001, American journal of respiratory cell and molecular biology.

[91]  P. Billings,et al.  Authentic Matrix Vesicles Contain Active Metalloproteases (MMP) , 2001, The Journal of Biological Chemistry.

[92]  D. Phillips,et al.  Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis. , 2001, Journal of hepatology.

[93]  R. Hruban,et al.  ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[94]  A. Roberts,et al.  The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. , 2001, Genes & development.

[95]  H. Wei,et al.  Expression changes of activin A in the development of hepatic fibrosis. , 2001, World journal of gastroenterology.

[96]  E. Montgomery,et al.  すい臓癌におけるACVR1B(ALK4、1B型アクチビン受容体)遺伝子の突然変異 , 2001 .

[97]  A. Roberts,et al.  Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis. , 2001, Advances in cancer research.

[98]  K. Tsuchida,et al.  Identification and Characterization of a Novel Follistatin-like Protein as a Binding Protein for the TGF-β Family* , 2000, The Journal of Biological Chemistry.

[99]  J E Moreira,et al.  Role of the conserved WHXL motif in the C terminus of synaptotagmin in synaptic vesicle docking. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[100]  A. Mason,et al.  Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit. , 2000, The Journal of clinical endocrinology and metabolism.

[101]  M. Matzuk,et al.  Activin βC and βE Genes Are Not Essential for Mouse Liver Growth, Differentiation, and Regeneration , 2000, Molecular and Cellular Biology.

[102]  T. Hayakawa,et al.  Expression of inhibin βA, βB, and follistatin mrnas in the carbon tetrachloride induced rat liver regeneration model , 2000 .

[103]  M. O’Bryan,et al.  Cloning and regulation of the rat activin betaE subunit. , 2000, Journal of molecular endocrinology.

[104]  S. Kanzler,et al.  Apoptosis and the liver. , 2000, Seminars in cancer biology.

[105]  G. Risbridger,et al.  Role of activins in the male reproductive tract. , 2000, Reviews of reproduction.

[106]  H. Kuwano,et al.  The role of activin and transforming growth factor‐β in the regulation of organ mass in the rat liver , 2000, Hepatology.

[107]  K. Matsuzaki,et al.  Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. , 2000, Journal of hepatology.

[108]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[109]  F. Petraglia,et al.  Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma. , 2000, Cancer detection and prevention.

[110]  M. Mitchell,et al.  Activin A exerts both pro- and anti-inflammatory effects on human term gestational tissues. , 2000, Placenta.

[111]  R. Balling,et al.  Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair , 1999, The EMBO journal.

[112]  C. Niehrs,et al.  Silencing of TGF-β signalling by the pseudoreceptor BAMBI , 1999, Nature.

[113]  M. Ozturk,et al.  Smad2 and Smad4 gene mutations in hepatocellular carcinoma , 1999, Oncogene.

[114]  T. Ishikawa,et al.  Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation. , 1999, Endocrinology.

[115]  J. Gurdon,et al.  Activin as a morphogen in Xenopus mesoderm induction. , 1999, Seminars in cell & developmental biology.

[116]  H. Friess,et al.  Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. , 1999, American journal of surgery.

[117]  D. Constam,et al.  Regulation of Bone Morphogenetic Protein Activity by Pro Domains and Proprotein Convertases , 1999, The Journal of cell biology.

[118]  H. Shibata,et al.  Immediate onset of DNA synthesis in remnant rat liver after 90% hepatectomy by an administration of follistatin. , 1998, Journal of hepatology.

[119]  H. Uchiyama,et al.  Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[120]  K. Mayo,et al.  Structure of the Rat Inhibin and Activin βA-Subunit Gene and Regulation in an Ovarian Granulosa Cell Line. , 1998, Endocrinology.

[121]  J. Magaud,et al.  FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders , 1998, Oncogene.

[122]  H. Asakura,et al.  Expression of activin A is increased in cirrhotic and fibrotic rat livers. , 1998, Gastroenterology.

[123]  J. Pedersen,et al.  Inhibins, activins, and follistatins: Expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasia , 1998, The Prostate.

[124]  P. Galle,et al.  CD95-induced apoptosis in human liver disease. , 1998, Seminars in liver disease (Print).

[125]  Pieter,et al.  Localization and cellular sources of activins in normal and fibrotic rat liver , 1997, Hepatology.

[126]  H. Schrewe,et al.  Reciprocal expression of mRNA for inhibin betaC and betaA subunits in hepatocytes. , 1997, Endocrine journal.

[127]  S. Perkins,et al.  The Factor I and follistatin domain families: the return of a prodigal son. , 1997, The Biochemical journal.

[128]  T. Zimmers,et al.  Transient down-regulation of inhibin-betaC expression following partial hepatectomy. , 1997, Biochemical and biophysical research communications.

[129]  Y. Hayashi,et al.  A Novel Role of Follistatin, an Activin-binding Protein, in the Inhibition of Activin Action in Rat Pituitary Cells , 1997, The Journal of Biological Chemistry.

[130]  J. Bonadio,et al.  Genes coding for mouse activin beta C and beta E are closely linked and exhibit a liver-specific expression pattern in adult tissues. , 1997, Biochemical and biophysical research communications.

[131]  Y. Nibu,et al.  Human activin betaA gene. Identification of novel 5' exon, functional promoter, and enhancers. , 1996, The Journal of biological chemistry.

[132]  J. Bonadio,et al.  Molecular cloning of the mouse activin beta E subunit gene. , 1996, Biochemical and biophysical research communications.

[133]  A. Mason,et al.  Characterization and determination of the biological activities of noncleavable high molecular weight forms of inhibin A and activin A. , 1996, Molecular Endocrinology.

[134]  Irene L Andrulis,et al.  MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.

[135]  K. Loveland,et al.  Expression of activin beta C subunit mRNA in reproductive tissues. , 1996, Journal of molecular endocrinology.

[136]  M. Matzuk,et al.  Structural analysis of the mouse activin beta C gene. , 1996, Biochimica et biophysica acta.

[137]  A. Gressner,et al.  Transforming growth factor β (TGF‐β) expression in isolated and cultured rat hepatocytes , 1996 .

[138]  W. Bursch,et al.  Transforming growth factor β1‐induced cell death in preneoplastic foci of rat liver and sensitization by the antiestrogen tamoxifen , 1996, Hepatology.

[139]  S. Thorgeirsson,et al.  The antiandrogen cyproterone acetate induces synthesis of transforming growth factor β1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation , 1996 .

[140]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[141]  D. Huylebroeck,et al.  Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors , 1996, Molecular and Cellular Endocrinology.

[142]  M. Merino,et al.  Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues , 1996, International journal of cancer.

[143]  J. Taipale,et al.  Association of the small latent transforming growth factor‐beta with an eight cysteine repeat of its binding protein LTBP‐1. , 1996, The EMBO journal.

[144]  D. Steiner,et al.  Proteolytic Processing Mechanisms in the Biosynthesis of Neuroendocrine Peptides: The Subtilisin-like Proprotein Convertases , 1995, Frontiers in Neuroendocrinology.

[145]  N. Ueno,et al.  Molecular cloning and functional analysis of a new activin beta subunit: a dorsal mesoderm-inducing activity in Xenopus. , 1995, Biochemical and biophysical research communications.

[146]  R. Leduc,et al.  Processing of Transforming Growth Factor 1 Precursor by Human Furin Convertase (*) , 1995, The Journal of Biological Chemistry.

[147]  M. Kanzaki,et al.  A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. , 1995, Gastroenterology.

[148]  Jianming Xu,et al.  Inhibin Antagonizes Inhibition of Liver Cell Growth by Activin by a Dominant-negative Mechanism (*) , 1995, The Journal of Biological Chemistry.

[149]  M. Kanzaki,et al.  Derangements in the activin-follistatin system in hepatoma cells. , 1995, Gastroenterology.

[150]  M. Kanzaki,et al.  Production of activin A and follistatin in cultured rat vascular smooth muscle cells , 1995, Molecular and Cellular Endocrinology.

[151]  Mann-Jy Chen,et al.  Mapping the Domain(s) Critical for the Binding of Human Tumor Necrosis Factor-α to Its Two Receptors (*) , 1995, The Journal of Biological Chemistry.

[152]  D. Robertson,et al.  Inhibin forms in human plasma. , 1995, The Journal of endocrinology.

[153]  C. Schneider,et al.  Cloning of a New Member of the TGF-β Family: A Putative New Activin βC Chain , 1995 .

[154]  W. Bursch,et al.  Active cell death (apoptosis) in liver biology and disease. , 1995, Progress in liver diseases.

[155]  R. Schwall,et al.  Induction of apoptosis in the murine liver with recombinant human activin a , 1994, Hepatology.

[156]  A. Bradley,et al.  Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[157]  W. Crowley,et al.  Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. , 1994, Endocrinology.

[158]  M. Tuite,et al.  Protein disulphide isomerase: building bridges in protein folding. , 1994, Trends in biochemical sciences.

[159]  K. Hildén,et al.  The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. , 1994, The Journal of clinical endocrinology and metabolism.

[160]  A. Mason.  Functional analysis of the cysteine residues of activin A. , 1994, Molecular endocrinology.

[161]  E. Allan,et al.  Plasminogen‐dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast‐like cells , 1993, Journal of cellular physiology.

[162]  J. Vaughan,et al.  Characterization and the regulation of inhibin/activin subunit proteins of cultured rat anterior pituitary cells. , 1993, Endocrinology.

[163]  N. Fausto.  Hepatocyte apoptosis: is transforming growth factor-B1 the kiss of death? , 1993, Hepatology.

[164]  T. Mine,et al.  Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. , 1993, The Journal of clinical investigation.

[165]  R. Schwall,et al.  Activin induces cell death in hepatocytes in vivo and in vitro , 1993, Hepatology.

[166]  N. Ling,et al.  Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. , 1993, The Journal of biological chemistry.

[167]  W. Hendrickson,et al.  A structural superfamily of growth factors containing a cystine knot motif , 1993, Cell.

[168]  J. Vaughan,et al.  Alpha 2-macroglobulin is a binding protein of inhibin and activin. , 1993, Endocrinology.

[169]  W. Bursch,et al.  Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. , 1993, British Journal of Cancer.

[170]  L. Madisen,et al.  Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within mature TGF beta 1: effects on secretion and bioactivity. , 1992, Molecular endocrinology.

[171]  W. Bursch,et al.  Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[172]  C. Chou,et al.  In Vitro Apoptosis in the Human Hepatoma Cell Line Induced by Transforming Growth Factor β1 , 1992 .

[173]  J. Findlay,et al.  Rat follistatin: ontogeny of steady-state mRNA levels in different tissues predicts organ-specific functions. , 1991, Biochemical and biophysical research communications.

[174]  K. Titani,et al.  Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells. , 1991, The Journal of biological chemistry.

[175]  W. Bursch,et al.  Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. , 1991, Cancer research.

[176]  H. Stunnenberg,et al.  Expression and processing of the activin-A/erythroid differentiation factor precursor: a member of the transforming growth factor-beta superfamily. , 1990, Molecular endocrinology.

[177]  A. Mason,et al.  Requirement for activin A and transforming growth factor--beta 1 pro-regions in homodimer assembly. , 1990, Science.

[178]  K. Titani,et al.  Activin-binding protein from rat ovary is follistatin. , 1990, Science.

[179]  A. Mason,et al.  Activin B: precursor sequences, genomic structure and in vitro activities. , 1989, Molecular endocrinology.

[180]  A. Brunner,et al.  Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins. , 1989, The Journal of biological chemistry.

[181]  A. Brunner,et al.  Transforming growth factor beta 1: importance of glycosylation and acidic proteases for processing and secretion. , 1989, Molecular endocrinology.

[182]  D. Rifkin,et al.  Alpha 2-macroglobulin is a binding protein for basic fibroblast growth factor. , 1989, The Journal of biological chemistry.

[183]  R. Coffey,et al.  Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[184]  N. Ling,et al.  Primary structure of the human follistatin precursor and its genomic organization. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[185]  W. Russell.  Transforming growth factor beta (TGF‐β) inhibits hepatocyte DNA synthesis independently of EGF binding and egf receptor autophosphorylation , 1988, Journal of cellular physiology.

[186]  S. S. Huang,et al.  Human transforming growth factor beta.alpha 2-macroglobulin complex is a latent form of transforming growth factor beta. , 1988, The Journal of biological chemistry.

[187]  N. Ling,et al.  Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[188]  N. Ling,et al.  A homodimer of the β-subunits of inhibin a stimulates the secretion of pituitary follicle stimulating hormone , 1986 .

[189]  Naoto Ueno,et al.  Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin , 1986, Nature.

[190]  Joan Vaughan,et al.  Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid , 1986, Nature.

[191]  N. Ling,et al.  Type beta transforming growth factor (TGF-beta) is a potent stimulator of the basal secretion of follicle stimulating hormone (FSH) in a pituitary monolayer system. , 1986, Biochemical and biophysical research communications.

[192]  H. Lodish.  Molecular Cell Biology , 1986 .

[193]  J. Vaughan,et al.  Purification and partial characterization of inhibin from porcine follicular fluid. , 1985, Biochemical and biophysical research communications.

[194]  D. Robertson,et al.  Inhibin: 1985 update on action and purification , 1985, Molecular and Cellular Endocrinology.

[195]  M. Sairam,et al.  ISOLATION AND CHARACTERIZATION OF INHIBIN FROM HUMAN SEMINAL PLASMA * , 1982, Annals of the New York Academy of Sciences.

[196]  A. Sheth,et al.  Isolation & characterization of inhibin from human seminal plasma. , 1978, Indian journal of experimental biology.

[197]  E. Daume,et al.  Purification of "inhibin" from human ovarian follicular fluid. , 1979, Acta endocrinologica.

[198]  N. Moudgal,et al.  Studies on purification and characterization of sheep testicular inhibin. , 1979, Journal of reproduction and fertility. Supplement.

[199]  D. R. Mccullagh.  DUAL ENDOCRINE ACTIVITY OF THE TESTES. , 1932, Science.

[200]  W. Cramer,et al.  ON THE GENERAL EFFECTS OF EXPOSURE TO RADIUM ON METABOLISM AND TUMOUR GROWTH IN THE RAT AND THE SPECIAL EFFECTS ON TESTIS AND PITUITARY , 1923 .